Who makes SoC therapy?

SoC therapy is developed by University of Campania Luigi Vanvitelli.

What development phase is SoC therapy in?

SoC therapy is FDA-approved (marketed).

Last reviewed 2026-04-22 · How we verify

SoC therapy

University of Campania Luigi Vanvitelli · FDA-approved active Small molecule

SoC therapy refers to a standard-of-care treatment regimen, typically combining multiple established therapeutic agents for a given condition.

At a glance

Generic name	SoC therapy
Sponsor	University of Campania Luigi Vanvitelli
Modality	Small molecule
Phase	FDA-approved

Mechanism of action

SoC (Standard of Care) is not a single drug but rather the accepted best-practice treatment approach for a specific disease, often comprising combination therapy with proven efficacy. The exact mechanism depends on the therapeutic agents included in the regimen for the particular indication being treated.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results